drugset / Trial / NCT03278730

Efficacy of Para-Tyrosine Supplementation on the Survival and Clinical Outcome in Patients With Sepsis

NCT03278730 ↗

Phase 2 Suspended 296 enrolled University of Pecs
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Meta-and ortho-Tyrosine are known markers of oxidative stress, while the physiological isomer, para-Tyrosine is suggested the antagonize the effects of meta- and ortho-Tyrosine. The changes in the serum levels of meta- and ortho-Tyrosine have been found to be paralel to that of the common sepsis markers. The hypothesis of the study is, that supplementation of para-Tyrosine (p-Tyr) in the early phase of sepsis may diminish some specific inflammatory procedures and thus may have a favourable impact on the disease progress, and consequently on the mortality.

Timeline

Start
2027-01
Primary completion
2027-01-01
Completion
2027-02-28

Outcome

Outcome not reported

Stopped: “Lack of resources to start”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator para-Tyrosine Unknown 2 g Other